TXN and cancer: Collectively, these studies reflect that superoxide dismutases protect β-catenin from ROS-driven degradation in both diabetic and cancer settings, while thioredoxin family proteins—Trx1, NRX, TrxR1—may serve as molecular switches that gate Dvl or β-catenin stability.